Symposium on Indian Ayurvedic Systems of Medicine
• 8:30 - 9:30 Welcome and Opening RemarksPresentation Session:
• Ikhlas Khan, Ph.D., Director CRISM
• Larry Walker, Ph.D., Co-Director, CRISM
• Greet Provoost, Director, Office of International Programs
The University of Mississippi.
Inauguration: Shri Sanjiv Arora, Honroable Consul General, Houston, Texas
Keynote Speaker: Ram Vishwakarma, Ph.D., Director, IIIM, Jammu.
Natural Products Driven Drug Discovery at the
Indian Institute of Integrative Medicine (IIIM).
Session Chair: Jeanne I. Rader, Ph.D., CFSAN/FDA.
• 9:30 - 10:00 S. K. Sharma, Ph.D., Adviser (Ayurveda) Department of
Indian Scenario of Drug Control and Standardization
of Ayurveda, Unani & Siddha Drugs, (2nd file)
•10:00 - 10:30 Meenakshi Negi, Smt., Director, AYUSH.
New Initiatives of AYUSH Department.
• 11:00 - 11:30 Bhaswati Bhattacharya, MD, Director,
The Dinacharya Institute. Implementing the Global
Propagation of Authentic Ayurveda.
• 11:30 - 12:00 Ranjit Puranik, Chief Executive Officer, Shree
Indian Regulatory Update.
• 1:00 - 1:30 P. Ram Manohar, Ph.D., Dir. of Research, AVTAR,
Diversity in the use of Botanicals in Clinical
Practice of Ayurveda: Research Perspectives.
• 1:30 - 2:00 Ramkumar Kutty, Ph.D., Managing Trustee Punarnava
Ayurveda Trust, Coimbatore. Optimal Healing Environments
- A Meeting Point for Ayurveda and Western Science.
• 2:00 - 2:30 Rama Jayasundar, Ph.D., Department of NMR, All India
Institute of Medical Sciences, Ansari Nagar, New Delhi.
Session 1 - Plenary Session: OCC Auditorium
Session Chair: Larry A. Walker, Ph.D., NCNPR, The University of Mississippi.• Ikhlas Khan, Ph.D., Director, UM FDA Center of Excellence.
• Matthias Hamburger, Ph.D., University of Basel, Switzerland. GA
• John Cardellina II, Ph.D., Reeves Group, ASP Representative
• De-An Guo, Ph.D., SIMM/CAS. Sino-US TCM Representative.• 9:30 - 10:00 (S-1) Robin Marles, Ph.D., Director, Health Canada.
Adventures in Regulation: seeking to define efficacy for
Natural Health Products in Canada.
•10:00 - 10:30 (S-2) Jack Killen, MD, Deputy Director,(NCCAM/NIH)
Current and Future Directions in CAM Research at
• 11:00 - 11:30 (S-5) Jeffery White, Ph.D., Director, (OCCAM/NIH).
Botanicals Research and Cancer: What is needed for
high-impact US clinical trials?
• 11:30 - 12:00 (S-3)Rainer Bussmann, Ph.D., Director, William L.
Brown Center, Missouri Botanical Garden.
William L. Brown Center’s global discovery program:
Markets, Healers, Vendors, Collectors and Modern
Applications. Medicinal Plant use in Northern Peru.
Concurrent Session 2a: Pharmacology, OCC Conference Room
Session Chair: Joseph M. Betz, Ph.D., Office of Dietary Supplements/NIH.
• 1:00 - 1:30 (S-6) Yung-Chi "Tommy" Cheng, Ph.D.,
Exploration of PHY906, a TCM formula as adjuvant
therapy for cancer patients undergoing chemotherapy.
• 1:30 - 2:00 (S-33) Wan-Sheng Chen, Ph.D., Second Military
University, Shanghai, P. R. China. - Contact
Inhibitory effect of Chinese Patent Medicines and natural
pure compounds on the catalytic activities of drug
• 2:00 - 2:30 (S-8) Bill Gurley, Ph.D., University of Arkansas for
Dosage Form Performance: An Overlooked Determinant
of Phytochemical Efficacy and Safety.
• 3:00 - 3:30 (S-11) Swarna Kaluthotage, Ph.D., Bandaranaike
Memorial Ayurvedic Research Institute, Sri Lanka.
Clinical Evaluation of the Efficacy of Plant Based
Product on Coronary Atherosclerosis..
• 3:30 - 4:00 (S-10) Veronika Butterweck, Ph.D., College of
Pharmacy, University of Florida. - Contact
Microarray analysis as a tool to elucidate the mechanism
of action of St. John’s wort.
• 4:00 - 4:30 (S-18) Amarasinghe A.P.G, Ph.D., Inst. of Indigenous
Medicine, University of Colombo, Sri Lanka.
A Study of Total Viable Count of Microorganisms and
Specific Microorganisms in Selected Ayurvedic Compound
Session 2b: Quality Assessment, OCC Magnolia room
Session Chair: N. Brown, M.Sc., MCIC, Integrative Bioscience Research Cluster,
British Columbia Institute of Technology• 1:00 - 1:30 (S-12) James Harnly, Ph.D., Agricultural Research
Service, USDA. - Contact
Spectral Fingerprinting for Determination of Panax
Species, Growing Site, and Treatment.
• 1:30 - 2:00 (S-13) Kimberly L. Colson, Ph.D., Bruker BioSpin.
NMR Based Screening Tool for Quality Control of
Botanical Dietary Supplements.
• 2:00 - 2:30 (S-14) A.B. Rema Shree, Ph.D., Center for Medicinal
Plants Research (CMPR), Kerala, India.
Marker Based Detection of Identity and Authenticity of
Raw Herbal Drugs and Finished Ayurvedic Products
for Quality Control and Standardization.
• 3:00 - 3:30 (S-17) Ji-kai Liu, Ph.D., State Key Laboratory of
Phytochemistry and Plant Resources in West China,
Kunming Chinese Academy of sciences, China.
Bioactive Secondary Metabolites from Higher Fungi
• 3:30 - 4:00 Bai Ping Ma, Ph.D., Beijing Institute of Radiation
Active Steroidal Saponins from Chinese Herbs.
• 4:00 - 4:30 (S-47) Maged Sharaf, Ph.D., United States Pharmacopeia.
USP's International Collaborations, Efforts Toward
Botanical Monographs Harmonization.
Session 4: Regulatory Aspects, OCC Auditorium
Session Chair: Elizabeth M. Calvey, Ph.D. CFSAN/FDA.
• 8:30 - 9:00 (S-19) Jennifer Burnett,
Therapeutic Goods Administration, Australia.
The Australian Regulation of Herbal Medicines:
• 9:00 - 9:30 (S-20) Fu-cheng Zhou, Ph.D.,
Chinese Pharmacopoeia Commission.
Introduction and development of TCM Volume of
Chinese Pharmacopeia 2010 edition.
• 9:30 - 10:00 (S-41) Giovanni Appendino, Ph.D., Indena, Italy.
Omne ignotum pro magnifico: Getting Bilberry out
of the Adulteration Swamp.
Concurrent Session 5a: Regulatory Aspects, OCC Auditorium
Session Chair: Ikhlas Khan, Ph.D., NCNPR, The University of Mississippi.
• 10:30 - 11:00 (S-23) Daryl Roberts, California District Attorney.
Prosecuting Dietary Supplement Fraud.
• 11:00 - 11:30 (S-24) Karen Jagielski, Bureau of Consumer
Regulations Governing the Advertising of
• 11:30 - 12:00 (S-22) Dan Levy, Ph.D., CFSAN/FDA
Recent experience with botanical ingredients submitted
compounds on the catalytic activities of drug
• 1:00 - 1:30 (S-25) Rui Chao Lin, Ph.D., SFDA, P. R. China.
Quality Control of Traditional Chinese Medicine
and Functional Foods. - Contact
• 1:30 - 2:00 (S-26) Daniel Eichner, United States Anti-Doping
Supplement Safety Now (SSN), a Public Protection
• 2:00 - 2:30 (S-21) Joao Ernesto de Carvalho, Ph.D., University of
Campinas, Brazil.Campinas, Brazil.
Regulatory Aspects of Phytomedicines and
Functional Foods in Brazil.
• 2:30 - 3:00 (S-27) Thomas Brendler, Ph.D., Plantaphile, Berlin,
Traditional Herbal Medicines - A Simplified Way of
Registering Herbal Medicines in the European Union?
Concurrent Session 5b: Pharmacognosy, OCC Magnolia room
Session Chair: K. Husnu Can Baser, Ph.D., Department of Pharmacognosy,
Anadolu University, Turkey.
• 10:30 - 11:00 (S-29) David Craik, Ph.D.,
University of Queensland, Australia
Naturally occurring cyclic proteins: discovery
and therapeutic applications.
• 11:00 - 11:30 James S. Miller, Ph.D., The New York Botanical
The Utility of DNA Barcoding for Identification
of Ingredients in Botanical Dietary Supplements.
• 11:30 - 12:00 (S-35) Weidong Zhang, Ph.D., Second Military
University, Shanghai, P. R. China. - Contact
Learning from History to Develop
Traditional Chinese Medicine.
• 1:00 - 1:30 (P-118) Kahawevidanalage Sudeepa Samanmalee
Sugathadasa, Bandaranaike Memorial Ayurvedic
Research Institute, Nawinna, Maharagama, Sri Lanka.
Effect of Fertilizer Application and Irrigation on
Agronomic Characters of Andrographis paniculata
(Burm. f.) Wall. ex Nees var. paniculata.
• 1:30 - 2:00 (S-31) Ren-Xiang Tan, Ph.D., Nanjing University,
Polyphenols from Hopea species (Dipterocarpaceae).
• 2:00 - 2:30 (P-4) Natascha Techen, Ph.D., NCNPR,
The University of Mississippi.
Quality and Quantity of DNA from Fresh and Long
Term Stored Samples.
Session 6: Global Perspectives, OCC Auditorium
Session Chair:James McChesney, Ph.D. Ironstone Separations, Inc, Etta, Mississippi.
• 8:30 - 9:00 (S-36) Izzy Kanfer, Ph.D., Rhodes University,
Medicinal Plants of South Africa: Phytochemistry,
Medicinal Claims & Commercial Exploitation
• 9:00 - 9:30 (S-38) Jinwoong Kim, Ph.D., Seoul National University,
Seoul National University, South Korea. - Contact
Systematic Investigation of Korean Herb Drugs
• 9:30 - 10:00 (S-39) Matthias Hamburger, Ph.D.,
University of Basel, Switzerland. - Contact
Chemical and Pharmacological Characterization of
Herbal Extracts by Profiling Approaches.
• 10:30 - 11:00 (S-44) Douglas ‘Duffy’ MacKay, ND, Council for
Responsible Nutrition. - Contact
Botanical Products: An Integrative Physician’s
• 11:00 - 11:30 (S-45) Bo-yang Yu, Ph.D., China Pharmaceutical
The Spectrum-Activity Integrated Fingerprint, an
Effective Method for the Quality Evaluation of
• 11:30 - 12:00 (S-46) Shen Ji, Ph.D., Shanghai Institute for Food
Chemical and Pharmacological Characterization
of Herbal Extracts by Profiling Approaches.
Session 7: Global Perspectives, OCC Auditorium
Session Chair: De-an Guo, Ph.D., Shanghai Institute of Materia Medica/Chinese
Academy of Sciences, P. R. China.• 1:00 - 1:30 (S-40) Shi-shan Yu,Chinese Academy of
Medical Sciences, P. R. China. - Contact
Study on Bioactive Compounds from Toxic Plants
• 1:30 - 2:00 (S-42) R. A. Jayasinghe,, Ph.D., IIM,
University of Colombo, Sri Lanka.
Plant based research and related legal framework
in Sri Lanka.
• 2:00 - 2:30 (S-43) Ling-yi Kong,, Ph.D., China Pharmaceutical
University, P. R. China - Contact
Chemical Constituents Study on Three Species
of Medicinal Plants.
• 3:00 - 3:30 De-an Guo, Ph.D., Shanghai Institute of Materia
Academy of Sciences, P. R. China.
Modernization of Traditional Chinese Medicine:
Challenges and Opportunities